Heylings J R
ICI Central Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom.
Toxicol Appl Pharmacol. 1991 Mar 1;107(3):482-93. doi: 10.1016/0041-008x(91)90311-2.
The gastrointestinal absorption of paraquat (1,1'-dimethyl-4,4'-bipyridylium) was studied using the isolated mucosa from different regions of the gastrointestinal tract of rats. Tissues were stripped of their muscle layers and the viability of the mucosa was maintained in flux chambers by bathing both serosal and luminal membranes with separate oxygenated solutions. Paraquat absorption, transmucosal potential difference (PD), and permeability of the mucosa were studied. Exposure of the luminal side of isolated mucosae to paraquat (100 mg/ml) resulted in greater paraquat absorption across the small intestine compared to other regions of the gastrointestinal tract. The descending order of tissue absorption (as %/cm2 mucosa) was jejunum (17.6 +/- 0.8%), ileum (10 +/- 2.7%), colon (5.7 +/- 3.2%), duodenum (5.5 +/- 1.3%), stomach (2 +/- 0.8%), and esophagus (0.5 +/- 0.7%). Mucosal uptake of paraquat in the ileum was nonlinear over a luminal concentration range 2-200 mg/ml. Three phases to paraquat absorption were identified in this region of the small intestine: (i) a rate which was faster than diffusion (2-20 mg/ml paraquat); (ii) a rate which was slower than diffusion and obeyed saturation kinetics, with an apparent Km = 116 mM and Vmax = 11.3 mumol/g/hr, at paraquat concentrations up to 150 mg/ml: and (iii) a rate similar to that of diffusion at 200 mg/ml paraquat. Paraquat absorption at 200 mg/ml was also associated with an increase in mucosal permeability and reduction in PD. Inhibition of tissue metabolism resulted in a linear or diffusional paraquat absorption over a wide luminal concentration range (2-200 mg/ml). It is suggested, therefore, that paraquat absorption in the rat occurs principally in the small intestine and by a mechanism which consists of facilitated, saturable, and diffusional components. Knowledge of the mechanism by which paraquat gains entry to the bloodstream may offer new approaches to the development of safer formulations of the herbicide.
利用大鼠胃肠道不同区域的离体黏膜研究了百草枯(1,1'-二甲基-4,4'-联吡啶鎓)的胃肠道吸收情况。去除组织的肌肉层,通过用单独的含氧溶液分别冲洗浆膜和腔面膜,在通量室中维持黏膜的活力。研究了百草枯的吸收、跨黏膜电位差(PD)和黏膜通透性。将离体黏膜的腔面暴露于百草枯(100 mg/ml)中,与胃肠道的其他区域相比,小肠对百草枯的吸收更多。组织吸收(以每平方厘米黏膜的百分比表示)的降序排列为:空肠(17.6±0.8%)、回肠(10±2.7%)、结肠(5.7±3.2%)、十二指肠(5.5±1.3%)、胃(2±0.8%)和食管(0.5±0.7%)。在2 - 200 mg/ml的腔面浓度范围内,回肠对百草枯的黏膜摄取是非线性的。在小肠的该区域确定了百草枯吸收的三个阶段:(i)速率快于扩散(2 - 20 mg/ml百草枯);(ii)速率慢于扩散且服从饱和动力学,在百草枯浓度高达150 mg/ml时,表观Km = 116 mM,Vmax = 11.3 μmol/g/小时;以及(iii)在200 mg/ml百草枯时速率与扩散相似。200 mg/ml时百草枯的吸收还与黏膜通透性增加和PD降低有关。组织代谢的抑制导致在较宽的腔面浓度范围(2 - 200 mg/ml)内百草枯吸收呈线性或扩散性。因此,提示大鼠体内百草枯的吸收主要发生在小肠,其机制包括易化、饱和和扩散成分。了解百草枯进入血液的机制可能为开发更安全的除草剂配方提供新方法。